Seminars in Oncology

Papers
(The H4-Index of Seminars in Oncology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment40
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance39
Breaking barriers: Deciphering the mechanisms of Olaparib resistance in prostate cancer28
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review26
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis18
Editorial Board17
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics17
Military exposures and lung cancer in United States Veterans16
Role of neoadjuvant pembrolizumab in advanced melanoma15
Explainable machine learning and feature interpretation to predict survival outcomes in the treatment of lung cancer15
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations13
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy response12
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans12
Adenocarcinoma on retrorectal cystic hamartoma: An illustrative image for a very rare diagnosis12
Table of Contents12
Editorial Board12
0.026139974594116